nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—CYP2D6—Parkinson's disease	0.666	1	CbGaD
Ropivacaine—SCN8A—cerebellar cortex—Parkinson's disease	0.0251	0.136	CbGeAlD
Ropivacaine—SCN8A—peripheral nervous system—Parkinson's disease	0.0118	0.0639	CbGeAlD
Ropivacaine—SCN8A—nerve—Parkinson's disease	0.00919	0.0498	CbGeAlD
Ropivacaine—SCN10A—peripheral nervous system—Parkinson's disease	0.00788	0.0428	CbGeAlD
Ropivacaine—SCN8A—hindbrain—Parkinson's disease	0.00688	0.0373	CbGeAlD
Ropivacaine—SCN10A—nerve—Parkinson's disease	0.00615	0.0334	CbGeAlD
Ropivacaine—SCN1A—hindbrain—Parkinson's disease	0.0052	0.0282	CbGeAlD
Ropivacaine—SCN2A—hindbrain—Parkinson's disease	0.00477	0.0259	CbGeAlD
Ropivacaine—SCN8A—brainstem—Parkinson's disease	0.00394	0.0214	CbGeAlD
Ropivacaine—SCN8A—forebrain—Parkinson's disease	0.00381	0.0207	CbGeAlD
Ropivacaine—SCN1A—brainstem—Parkinson's disease	0.00298	0.0162	CbGeAlD
Ropivacaine—SCN1A—forebrain—Parkinson's disease	0.00288	0.0156	CbGeAlD
Ropivacaine—SCN2A—brainstem—Parkinson's disease	0.00274	0.0148	CbGeAlD
Ropivacaine—SCN2A—forebrain—Parkinson's disease	0.00264	0.0143	CbGeAlD
Ropivacaine—SCN10A—forebrain—Parkinson's disease	0.00255	0.0138	CbGeAlD
Ropivacaine—SCN8A—spinal cord—Parkinson's disease	0.00245	0.0133	CbGeAlD
Ropivacaine—SCN3A—forebrain—Parkinson's disease	0.00232	0.0126	CbGeAlD
Ropivacaine—SCN9A—midbrain—Parkinson's disease	0.00221	0.012	CbGeAlD
Ropivacaine—SCN8A—head—Parkinson's disease	0.00218	0.0118	CbGeAlD
Ropivacaine—SCN9A—spinal cord—Parkinson's disease	0.00215	0.0117	CbGeAlD
Ropivacaine—SCN1A—medulla oblongata—Parkinson's disease	0.00208	0.0113	CbGeAlD
Ropivacaine—SCN8A—nervous system—Parkinson's disease	0.00207	0.0112	CbGeAlD
Ropivacaine—SCN8A—central nervous system—Parkinson's disease	0.00199	0.0108	CbGeAlD
Ropivacaine—SCN5A—cardiovascular system—Parkinson's disease	0.00196	0.0106	CbGeAlD
Ropivacaine—SCN8A—cerebellum—Parkinson's disease	0.00194	0.0106	CbGeAlD
Ropivacaine—SCN2A—medulla oblongata—Parkinson's disease	0.00191	0.0104	CbGeAlD
Ropivacaine—SCN1A—midbrain—Parkinson's disease	0.0019	0.0103	CbGeAlD
Ropivacaine—SCN1A—spinal cord—Parkinson's disease	0.00185	0.0101	CbGeAlD
Ropivacaine—SCN2A—midbrain—Parkinson's disease	0.00174	0.00946	CbGeAlD
Ropivacaine—SCN4A—head—Parkinson's disease	0.00171	0.00927	CbGeAlD
Ropivacaine—SCN2A—spinal cord—Parkinson's disease	0.0017	0.00923	CbGeAlD
Ropivacaine—SCN3A—medulla oblongata—Parkinson's disease	0.00168	0.0091	CbGeAlD
Ropivacaine—SCN1A—head—Parkinson's disease	0.00165	0.00894	CbGeAlD
Ropivacaine—SCN10A—spinal cord—Parkinson's disease	0.00164	0.0089	CbGeAlD
Ropivacaine—SCN4A—nervous system—Parkinson's disease	0.00162	0.00879	CbGeAlD
Ropivacaine—SCN8A—brain—Parkinson's disease	0.00158	0.00857	CbGeAlD
Ropivacaine—CYP2D6—hindbrain—Parkinson's disease	0.00157	0.00851	CbGeAlD
Ropivacaine—SCN1A—nervous system—Parkinson's disease	0.00156	0.00848	CbGeAlD
Ropivacaine—SCN4A—central nervous system—Parkinson's disease	0.00156	0.00846	CbGeAlD
Ropivacaine—SCN3A—midbrain—Parkinson's disease	0.00153	0.00832	CbGeAlD
Ropivacaine—SCN2A—head—Parkinson's disease	0.00151	0.0082	CbGeAlD
Ropivacaine—SCN1A—central nervous system—Parkinson's disease	0.0015	0.00816	CbGeAlD
Ropivacaine—SCN3A—spinal cord—Parkinson's disease	0.0015	0.00811	CbGeAlD
Ropivacaine—Ranolazine—CYP2D6—Parkinson's disease	0.00148	0.337	CrCbGaD
Ropivacaine—SCN1A—cerebellum—Parkinson's disease	0.00147	0.00798	CbGeAlD
Ropivacaine—SCN10A—head—Parkinson's disease	0.00146	0.00791	CbGeAlD
Ropivacaine—Bupivacaine—CYP2D6—Parkinson's disease	0.00145	0.331	CrCbGaD
Ropivacaine—SCN2A—nervous system—Parkinson's disease	0.00143	0.00778	CbGeAlD
Ropivacaine—SCN9A—brain—Parkinson's disease	0.00139	0.00753	CbGeAlD
Ropivacaine—SCN10A—nervous system—Parkinson's disease	0.00138	0.0075	CbGeAlD
Ropivacaine—SCN2A—central nervous system—Parkinson's disease	0.00138	0.00749	CbGeAlD
Ropivacaine—SCN2A—cerebellum—Parkinson's disease	0.00135	0.00732	CbGeAlD
Ropivacaine—SCN10A—central nervous system—Parkinson's disease	0.00133	0.00722	CbGeAlD
Ropivacaine—SCN3A—head—Parkinson's disease	0.00133	0.00721	CbGeAlD
Ropivacaine—SCN5A—head—Parkinson's disease	0.00133	0.00719	CbGeAlD
Ropivacaine—SCN3A—nervous system—Parkinson's disease	0.00126	0.00684	CbGeAlD
Ropivacaine—SCN5A—nervous system—Parkinson's disease	0.00126	0.00682	CbGeAlD
Ropivacaine—SCN4A—brain—Parkinson's disease	0.00124	0.00672	CbGeAlD
Ropivacaine—SCN3A—central nervous system—Parkinson's disease	0.00121	0.00658	CbGeAlD
Ropivacaine—SCN5A—central nervous system—Parkinson's disease	0.00121	0.00656	CbGeAlD
Ropivacaine—SCN1A—brain—Parkinson's disease	0.00119	0.00648	CbGeAlD
Ropivacaine—SCN3A—cerebellum—Parkinson's disease	0.00119	0.00643	CbGeAlD
Ropivacaine—SCN2A—brain—Parkinson's disease	0.0011	0.00595	CbGeAlD
Ropivacaine—SCN10A—brain—Parkinson's disease	0.00106	0.00573	CbGeAlD
Ropivacaine—CYP2B6—cardiovascular system—Parkinson's disease	0.000987	0.00536	CbGeAlD
Ropivacaine—SCN3A—brain—Parkinson's disease	0.000963	0.00523	CbGeAlD
Ropivacaine—SCN5A—brain—Parkinson's disease	0.00096	0.00521	CbGeAlD
Ropivacaine—CYP2D6—brainstem—Parkinson's disease	0.000899	0.00488	CbGeAlD
Ropivacaine—CYP2D6—forebrain—Parkinson's disease	0.000868	0.00471	CbGeAlD
Ropivacaine—Lidocaine—CYP2D6—Parkinson's disease	0.00085	0.194	CrCbGaD
Ropivacaine—CYP2B6—head—Parkinson's disease	0.000669	0.00363	CbGeAlD
Ropivacaine—CYP2B6—nervous system—Parkinson's disease	0.000634	0.00344	CbGeAlD
Ropivacaine—CYP2B6—central nervous system—Parkinson's disease	0.00061	0.00331	CbGeAlD
Ropivacaine—Lidocaine—ABCB1—Parkinson's disease	0.000607	0.138	CrCbGaD
Ropivacaine—CYP2D6—head—Parkinson's disease	0.000497	0.0027	CbGeAlD
Ropivacaine—CYP2B6—brain—Parkinson's disease	0.000485	0.00263	CbGeAlD
Ropivacaine—CYP3A4—nervous system—Parkinson's disease	0.000479	0.0026	CbGeAlD
Ropivacaine—CYP2D6—nervous system—Parkinson's disease	0.000471	0.00256	CbGeAlD
Ropivacaine—CYP3A4—central nervous system—Parkinson's disease	0.000461	0.0025	CbGeAlD
Ropivacaine—CYP2D6—central nervous system—Parkinson's disease	0.000454	0.00246	CbGeAlD
Ropivacaine—CYP2D6—cerebellum—Parkinson's disease	0.000443	0.00241	CbGeAlD
Ropivacaine—CYP2D6—brain—Parkinson's disease	0.00036	0.00195	CbGeAlD
Ropivacaine—SCN4A—Developmental Biology—GRIN2B—Parkinson's disease	0.000227	0.00157	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—DLG4—Parkinson's disease	0.000224	0.00155	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—DLG4—Parkinson's disease	0.000224	0.00155	CbGpPWpGaD
Ropivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000222	0.00153	CbGpPWpGaD
Ropivacaine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000221	0.00153	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—DLG4—Parkinson's disease	0.000221	0.00152	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—GRIN2B—Parkinson's disease	0.000219	0.00151	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—GRIN2B—Parkinson's disease	0.000219	0.00151	CbGpPWpGaD
Ropivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000219	0.00151	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—GRIN2B—Parkinson's disease	0.000216	0.00149	CbGpPWpGaD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000213	0.00147	CbGpPWpGaD
Ropivacaine—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000212	0.00146	CbGpPWpGaD
Ropivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000211	0.00145	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000204	0.00141	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—ABL1—Parkinson's disease	0.000202	0.00139	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000197	0.00136	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—ABL1—Parkinson's disease	0.000193	0.00133	CbGpPWpGaD
Ropivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000187	0.00129	CbGpPWpGaD
Ropivacaine—CYP1A2—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.000187	0.00129	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	0.000186	0.00128	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—ABL1—Parkinson's disease	0.000185	0.00128	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—ABL1—Parkinson's disease	0.000185	0.00128	CbGpPWpGaD
Ropivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000185	0.00128	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000184	0.00127	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00018	0.00124	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—ABL1—Parkinson's disease	0.000179	0.00123	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—ABL1—Parkinson's disease	0.000179	0.00123	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—CYP2D6—Parkinson's disease	0.000178	0.00122	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—ABL1—Parkinson's disease	0.000176	0.00121	CbGpPWpGaD
Ropivacaine—CYP2B6—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000175	0.00121	CbGpPWpGaD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000175	0.00121	CbGpPWpGaD
Ropivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000171	0.00118	CbGpPWpGaD
Ropivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000169	0.00117	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—HSPA8—Parkinson's disease	0.000168	0.00116	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	0.000166	0.00115	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—INS—Parkinson's disease	0.000165	0.00114	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—CYP2E1—Parkinson's disease	0.000162	0.00112	CbGpPWpGaD
Ropivacaine—CYP2B6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00016	0.0011	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—GSTA4—Parkinson's disease	0.000158	0.00109	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—DLG4—Parkinson's disease	0.000158	0.00109	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000156	0.00107	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000156	0.00107	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000156	0.00107	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—GRIN2B—Parkinson's disease	0.000154	0.00106	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000152	0.00105	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000148	0.00102	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—MAOB—Parkinson's disease	0.000141	0.00097	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000139	0.000958	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase II conjugation—COMT—Parkinson's disease	0.000136	0.000934	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase II conjugation—GSTP1—Parkinson's disease	0.000135	0.00093	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—COMT—Parkinson's disease	0.000135	0.000928	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—GSTP1—Parkinson's disease	0.000134	0.000924	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—MAOA—Parkinson's disease	0.000134	0.000922	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—INS—Parkinson's disease	0.000133	0.000919	CbGpPWpGaD
Ropivacaine—CYP2B6—Metapathway biotransformation—COMT—Parkinson's disease	0.000133	0.000915	CbGpPWpGaD
Ropivacaine—CYP2B6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000132	0.000911	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—INS—Parkinson's disease	0.000128	0.000879	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—ABL1—Parkinson's disease	0.000126	0.000866	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	0.000124	0.000854	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—GSTM1—Parkinson's disease	0.000123	0.000849	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—INS—Parkinson's disease	0.000123	0.000845	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—INS—Parkinson's disease	0.000123	0.000845	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000122	0.00084	CbGpPWpGaD
Ropivacaine—CYP2B6—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000121	0.000837	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00012	0.000829	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—INS—Parkinson's disease	0.000118	0.000814	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—INS—Parkinson's disease	0.000118	0.000814	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000114	0.000788	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000113	0.00078	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	0.000113	0.000779	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000111	0.000768	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	0.000109	0.000753	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000109	0.000749	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	0.000105	0.000721	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000103	0.000711	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—IL6—Parkinson's disease	0.000101	0.000696	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	9.57e-05	0.00066	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	9.44e-05	0.00065	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—COMT—Parkinson's disease	9.36e-05	0.000645	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	9.31e-05	0.000642	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	9.29e-05	0.000641	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	9.23e-05	0.000636	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	9.19e-05	0.000633	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	9.13e-05	0.000629	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—TNF—Parkinson's disease	8.93e-05	0.000615	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	8.75e-05	0.000603	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ND3—Parkinson's disease	8.73e-05	0.000602	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—MCCC1—Parkinson's disease	8.73e-05	0.000602	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	8.56e-05	0.00059	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	8.44e-05	0.000582	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—INS—Parkinson's disease	8.31e-05	0.000573	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—TALDO1—Parkinson's disease	8.21e-05	0.000566	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—OMD—Parkinson's disease	8.21e-05	0.000566	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—IL6—Parkinson's disease	8.16e-05	0.000563	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	8.07e-05	0.000557	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	7.96e-05	0.000549	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—COMT—Parkinson's disease	7.93e-05	0.000546	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	7.93e-05	0.000546	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	7.93e-05	0.000546	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	7.89e-05	0.000544	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	7.87e-05	0.000543	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	7.82e-05	0.000539	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—IL6—Parkinson's disease	7.81e-05	0.000538	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NDUFB11—Parkinson's disease	7.78e-05	0.000536	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	7.78e-05	0.000536	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—IL6—Parkinson's disease	7.5e-05	0.000517	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—IL6—Parkinson's disease	7.5e-05	0.000517	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GCH1—Parkinson's disease	7.42e-05	0.000512	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	7.38e-05	0.000509	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	7.28e-05	0.000502	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	7.25e-05	0.0005	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—IL6—Parkinson's disease	7.23e-05	0.000499	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—IL6—Parkinson's disease	7.23e-05	0.000499	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—TNF—Parkinson's disease	7.22e-05	0.000498	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—IL6—Parkinson's disease	7.2e-05	0.000497	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	7.15e-05	0.000493	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—TNF—Parkinson's disease	6.91e-05	0.000476	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—TNF—Parkinson's disease	6.63e-05	0.000457	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—TNF—Parkinson's disease	6.63e-05	0.000457	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GBA—Parkinson's disease	6.62e-05	0.000456	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—FBP1—Parkinson's disease	6.62e-05	0.000456	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—DBH—Parkinson's disease	6.62e-05	0.000456	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—TNF—Parkinson's disease	6.4e-05	0.000441	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—TNF—Parkinson's disease	6.4e-05	0.000441	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—COMT—Parkinson's disease	6.12e-05	0.000422	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	6.09e-05	0.00042	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	6.07e-05	0.000419	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ND3—Parkinson's disease	6.07e-05	0.000418	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—MCCC1—Parkinson's disease	6.07e-05	0.000418	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	6.03e-05	0.000416	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	6.01e-05	0.000414	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—IL6—Parkinson's disease	5.83e-05	0.000402	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—TALDO1—Parkinson's disease	5.71e-05	0.000393	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—OMD—Parkinson's disease	5.71e-05	0.000393	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	5.6e-05	0.000386	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—IL6—Parkinson's disease	5.57e-05	0.000384	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	5.52e-05	0.00038	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	5.46e-05	0.000376	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	5.41e-05	0.000373	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—IL6—Parkinson's disease	5.35e-05	0.000369	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—IL6—Parkinson's disease	5.35e-05	0.000369	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—IL6—Parkinson's disease	5.16e-05	0.000356	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—IL6—Parkinson's disease	5.16e-05	0.000356	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GCH1—Parkinson's disease	5.16e-05	0.000356	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—MCCC1—Parkinson's disease	5.14e-05	0.000354	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ND3—Parkinson's disease	5.14e-05	0.000354	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—IL6—Parkinson's disease	5.09e-05	0.000351	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—DDC—Parkinson's disease	4.86e-05	0.000335	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—TALDO1—Parkinson's disease	4.83e-05	0.000333	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—OMD—Parkinson's disease	4.83e-05	0.000333	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—DBH—Parkinson's disease	4.6e-05	0.000317	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—FBP1—Parkinson's disease	4.6e-05	0.000317	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GBA—Parkinson's disease	4.6e-05	0.000317	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTA4—Parkinson's disease	4.59e-05	0.000316	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	4.58e-05	0.000316	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—TNF—Parkinson's disease	4.5e-05	0.00031	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GCH1—Parkinson's disease	4.37e-05	0.000301	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PLA2G6—Parkinson's disease	4.13e-05	0.000285	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—MAOB—Parkinson's disease	4.09e-05	0.000282	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ND3—Parkinson's disease	3.97e-05	0.000273	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	3.97e-05	0.000273	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.94e-05	0.000272	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GBA—Parkinson's disease	3.9e-05	0.000269	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—DBH—Parkinson's disease	3.9e-05	0.000269	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—FBP1—Parkinson's disease	3.9e-05	0.000269	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—OMD—Parkinson's disease	3.73e-05	0.000257	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	3.73e-05	0.000257	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—IL6—Parkinson's disease	3.63e-05	0.00025	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	3.54e-05	0.000244	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—DDC—Parkinson's disease	3.38e-05	0.000233	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GCH1—Parkinson's disease	3.37e-05	0.000233	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	3.19e-05	0.00022	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP2D6—Parkinson's disease	3.04e-05	0.000209	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GBA—Parkinson's disease	3.01e-05	0.000207	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—FBP1—Parkinson's disease	3.01e-05	0.000207	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—DBH—Parkinson's disease	3.01e-05	0.000207	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CTGF—Parkinson's disease	2.98e-05	0.000206	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.87e-05	0.000198	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—DDC—Parkinson's disease	2.86e-05	0.000197	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.84e-05	0.000196	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP2E1—Parkinson's disease	2.78e-05	0.000192	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NQO1—Parkinson's disease	2.75e-05	0.000189	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—TH—Parkinson's disease	2.71e-05	0.000187	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTA4—Parkinson's disease	2.7e-05	0.000186	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.67e-05	0.000184	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYCS—Parkinson's disease	2.6e-05	0.000179	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	2.43e-05	0.000168	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—MAOB—Parkinson's disease	2.41e-05	0.000166	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—COMT—Parkinson's disease	2.3e-05	0.000159	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTP1—Parkinson's disease	2.29e-05	0.000158	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.29e-05	0.000158	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—MAOA—Parkinson's disease	2.29e-05	0.000158	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—HMOX1—Parkinson's disease	2.26e-05	0.000156	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—DDC—Parkinson's disease	2.21e-05	0.000152	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ABCB1—Parkinson's disease	2.17e-05	0.00015	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTM1—Parkinson's disease	2.11e-05	0.000145	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.08e-05	0.000144	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.07e-05	0.000143	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GPX1—Parkinson's disease	2.02e-05	0.000139	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.93e-05	0.000133	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.91e-05	0.000132	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—TH—Parkinson's disease	1.88e-05	0.00013	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.88e-05	0.000129	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—MTHFR—Parkinson's disease	1.86e-05	0.000128	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.86e-05	0.000128	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.81e-05	0.000125	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	1.79e-05	0.000123	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CTGF—Parkinson's disease	1.76e-05	0.000121	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—APOE—Parkinson's disease	1.73e-05	0.000119	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	1.64e-05	0.000113	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NQO1—Parkinson's disease	1.62e-05	0.000112	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—COMT—Parkinson's disease	1.6e-05	0.00011	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—TH—Parkinson's disease	1.59e-05	0.00011	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.59e-05	0.00011	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.59e-05	0.00011	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.57e-05	0.000108	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYCS—Parkinson's disease	1.53e-05	0.000106	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.51e-05	0.000104	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—INS—Parkinson's disease	1.48e-05	0.000102	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.46e-05	0.000101	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.4e-05	9.66e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.38e-05	9.52e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—COMT—Parkinson's disease	1.36e-05	9.35e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.36e-05	9.34e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTP1—Parkinson's disease	1.35e-05	9.3e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—MAOA—Parkinson's disease	1.35e-05	9.28e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HMOX1—Parkinson's disease	1.33e-05	9.17e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.29e-05	8.92e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ABCB1—Parkinson's disease	1.28e-05	8.8e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.26e-05	8.7e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.25e-05	8.61e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTM1—Parkinson's disease	1.24e-05	8.55e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—TH—Parkinson's disease	1.23e-05	8.48e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—APOE—Parkinson's disease	1.2e-05	8.3e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GPX1—Parkinson's disease	1.19e-05	8.19e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.18e-05	8.14e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—MTHFR—Parkinson's disease	1.1e-05	7.55e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—COMT—Parkinson's disease	1.05e-05	7.21e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.04e-05	7.18e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.04e-05	7.16e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—INS—Parkinson's disease	1.03e-05	7.09e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.03e-05	7.08e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—APOE—Parkinson's disease	1.02e-05	7.03e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	9.86e-06	6.8e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	9.57e-06	6.6e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GPX1—Parkinson's disease	9.16e-06	6.32e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—INS—Parkinson's disease	8.72e-06	6.01e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	8.46e-06	5.83e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—APOE—Parkinson's disease	7.87e-06	5.43e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—INS—Parkinson's disease	6.73e-06	4.64e-05	CbGpPWpGaD
